Name | Number of supported studies | Average coverage | |
---|---|---|---|
retinal ganglion cell | 6 studies | 62% ± 33% | |
neuron | 4 studies | 65% ± 26% |
Insufficient scRNA-seq data for expression of PRPH at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 99% | 918.12 | 958 / 966 | 8% | 0.22 | 42 / 527 |
uterus | 80% | 146.68 | 136 / 170 | 19% | 2.22 | 85 / 459 |
adrenal gland | 33% | 128.09 | 85 / 258 | 65% | 28.89 | 149 / 230 |
bladder | 86% | 90.38 | 18 / 21 | 7% | 0.16 | 33 / 504 |
brain | 28% | 52.32 | 739 / 2642 | 62% | 2.10 | 435 / 705 |
adipose | 88% | 202.15 | 1055 / 1204 | 0% | 0 | 0 / 0 |
pancreas | 45% | 37.79 | 146 / 328 | 42% | 2.67 | 74 / 178 |
spleen | 85% | 92.22 | 205 / 241 | 0% | 0 | 0 / 0 |
breast | 78% | 121.53 | 356 / 459 | 6% | 0.20 | 65 / 1118 |
prostate | 77% | 169.38 | 188 / 245 | 6% | 0.18 | 29 / 502 |
blood vessel | 69% | 95.79 | 918 / 1335 | 0% | 0 | 0 / 0 |
esophagus | 59% | 196.73 | 859 / 1445 | 8% | 0.15 | 14 / 183 |
stomach | 58% | 249.05 | 209 / 359 | 9% | 0.22 | 25 / 286 |
lung | 57% | 66.76 | 330 / 578 | 6% | 0.17 | 65 / 1155 |
ovary | 39% | 42.86 | 70 / 180 | 15% | 0.45 | 63 / 430 |
thymus | 42% | 31.93 | 272 / 653 | 12% | 0.25 | 71 / 605 |
skin | 45% | 40.44 | 811 / 1809 | 7% | 0.29 | 32 / 472 |
kidney | 18% | 15.64 | 16 / 89 | 13% | 0.51 | 115 / 901 |
heart | 26% | 25.37 | 225 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.34 | 4 / 45 |
muscle | 3% | 2.44 | 25 / 803 | 0% | 0 | 0 / 0 |
liver | 1% | 0.60 | 2 / 226 | 2% | 0.04 | 7 / 406 |
eye | 0% | 0 | 0 / 0 | 3% | 0.15 | 2 / 80 |
peripheral blood | 0% | 0.05 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0043204 | Cellular component | perikaryon |
GO_0045098 | Cellular component | type III intermediate filament |
GO_0030424 | Cellular component | axon |
GO_0005737 | Cellular component | cytoplasm |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005882 | Cellular component | intermediate filament |
GO_0005515 | Molecular function | protein binding |
GO_0005198 | Molecular function | structural molecule activity |
Gene name | PRPH |
Protein name | Peripherin (Neurofilament 4) Peripherin |
Synonyms | NEF4 PRPH1 |
Description | FUNCTION: Class-III neuronal intermediate filament protein (By similarity). May form an independent structural network without the involvement of other neurofilaments or may cooperate with the neuronal intermediate filament proteins NEFL, NEFH, NEFM and INA to form a filamentous network . Assembly of the neuronal intermediate filaments may be regulated by RAB7A (By similarity). Plays a role in the development of unmyelinated sensory neurons (By similarity). May be involved in axon elongation and axon regeneration after injury (By similarity). Inhibits neurite extension in type II spiral ganglion neurons in the cochlea (By similarity). . |
Accessions | ENST00000451891.4 H7C5W5 F8W835 ENST00000257860.9 [P41219-1] P41219 ENST00000532332.2 |